US Stock MarketDetailed Quotes
JSPRW JASPER THERAPEUTICS INC C/WTS 01/12/2026 (TO PUR COM)
Watchlist
0.1200
0.00000.00% Close 06/08 16:00 ET
0.1587High0.1110Low1.26KVolume
0.1318Open0.1200Pre Close161.00Turnover0.00%Turnover Ratio0.00P/E (TTM)0Market Cap0.253452wk High0.00P/E (Static)0Shares0.016052wk Low0.00P/B0Float Cap2.2400Historical High--Dividend TTM0Shs Float0.0160Historical Low--Div YieldTTM39.75%Amplitude0.1270Avg Price1Lot Size
Company Profile
Symbol
JSPRW
Company Name
JASPER THERAPEUTICS INC C/WTS 01/12/2026 (TO PUR COM)
Listing Date
01/10/2020
Founded
2018
CEO
Mr. Ronald A. Martell
Market
NASDAQ
Employees
35
Securities Type
Ordinary Shares
Fiscal Year Ends
12-31
Address
2200 Bridge Parkway,Suite 102
City
Redwood City
Province
California
Country
United States of America
Zip Code
94065
Phone
1-650-549-1400
Description
Jasper Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in enabling cures through hematopoietic stem cell therapy. It focuses on the development and commercialization of safer, stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of cells is performed outside of the body prior to transplantation. The company was founded by Judith Shizuru and Susan Prohaska in March 2018 and is headquartered in Redwood City, CA.
Company Executives
No Data